Cargando…

Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast

Introduction Papillary breast lesions are segregated into benign and malignant based on the presence or absence of myoepithelial cells in the papillary cores. Papillary breast lesions are further classified into: intraductal papilloma, papilloma with atypical ductal hyperplasia (ADH)/ductal carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashmi, Atif A, Faraz, Mahrukh, Rafique, Sana, Adil, Hiba, Imran, Abira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671300/
https://www.ncbi.nlm.nih.gov/pubmed/33214954
http://dx.doi.org/10.7759/cureus.11026
_version_ 1783610903613145088
author Hashmi, Atif A
Faraz, Mahrukh
Rafique, Sana
Adil, Hiba
Imran, Abira
author_facet Hashmi, Atif A
Faraz, Mahrukh
Rafique, Sana
Adil, Hiba
Imran, Abira
author_sort Hashmi, Atif A
collection PubMed
description Introduction Papillary breast lesions are segregated into benign and malignant based on the presence or absence of myoepithelial cells in the papillary cores. Papillary breast lesions are further classified into: intraductal papilloma, papilloma with atypical ductal hyperplasia (ADH)/ductal carcinoma in situ (DCIS), papillary DCIS, solid papillary carcinoma in situ, solid papillary carcinoma with invasion, invasive solid papillary carcinoma, encapsulated papillary carcinoma and encapsulated papillary carcinoma with invasion. In this study, we evaluated the spectrum of papillary breast lesions in resection specimens of the breast according to the latest World Health Organization (WHO) classification of breast tumors. Methods This was a retrospective cross-sectional study, and was conducted at Liaquat National Hospital for a period of six years, from January 2012 till December 2017. Data of patients that underwent surgeries for breast tumors were included in the study. All specimens were grossed, according to defined protocols, and representative sections were taken after inking resection margins. Hematoxylin and eosin-stained sections were examined by experienced histopathologists, and myoepithelial stains (p63 and myosin) were done in selected sections of all tumors. Histopathological classification of papillary tumors was performed according to WHO classification of breast tumors. Results The study involved 190 excision specimens of papillary breast lesions. Mean age of the patients was 45.6±17.1 years. Most of the lesions were between two and five centimetres (69.1%). For invasive carcinomas (n = 76), the most frequent grade was II (52.6%). For in situ and invasive carcinomas (n = 129), lymphovascular invasion and axillary metastasis were noted in 5.4% and 9.3% cases, respectively. Among papillary breast lesions, 36.8% were benign (intraductal papilloma, solitary or multiple) while 63.2% harbored ADH, DCIS, or invasive carcinoma. Invasive papillary carcinoma was the most frequent malignant papillary lesion (20%), followed by solid papillary carcinoma with invasion (12.6%). We found significant associations between patient’s age and tumor size with histological type of papillary lesion as benign papillary lesions had smaller size and younger age compared to malignant papillary lesions. Conclusion We noted a high frequency of malignancy in papillary breast lesions. Moreover, malignant papillary lesions were significantly associated with higher age and larger tumor size.
format Online
Article
Text
id pubmed-7671300
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76713002020-11-18 Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast Hashmi, Atif A Faraz, Mahrukh Rafique, Sana Adil, Hiba Imran, Abira Cureus Pathology Introduction Papillary breast lesions are segregated into benign and malignant based on the presence or absence of myoepithelial cells in the papillary cores. Papillary breast lesions are further classified into: intraductal papilloma, papilloma with atypical ductal hyperplasia (ADH)/ductal carcinoma in situ (DCIS), papillary DCIS, solid papillary carcinoma in situ, solid papillary carcinoma with invasion, invasive solid papillary carcinoma, encapsulated papillary carcinoma and encapsulated papillary carcinoma with invasion. In this study, we evaluated the spectrum of papillary breast lesions in resection specimens of the breast according to the latest World Health Organization (WHO) classification of breast tumors. Methods This was a retrospective cross-sectional study, and was conducted at Liaquat National Hospital for a period of six years, from January 2012 till December 2017. Data of patients that underwent surgeries for breast tumors were included in the study. All specimens were grossed, according to defined protocols, and representative sections were taken after inking resection margins. Hematoxylin and eosin-stained sections were examined by experienced histopathologists, and myoepithelial stains (p63 and myosin) were done in selected sections of all tumors. Histopathological classification of papillary tumors was performed according to WHO classification of breast tumors. Results The study involved 190 excision specimens of papillary breast lesions. Mean age of the patients was 45.6±17.1 years. Most of the lesions were between two and five centimetres (69.1%). For invasive carcinomas (n = 76), the most frequent grade was II (52.6%). For in situ and invasive carcinomas (n = 129), lymphovascular invasion and axillary metastasis were noted in 5.4% and 9.3% cases, respectively. Among papillary breast lesions, 36.8% were benign (intraductal papilloma, solitary or multiple) while 63.2% harbored ADH, DCIS, or invasive carcinoma. Invasive papillary carcinoma was the most frequent malignant papillary lesion (20%), followed by solid papillary carcinoma with invasion (12.6%). We found significant associations between patient’s age and tumor size with histological type of papillary lesion as benign papillary lesions had smaller size and younger age compared to malignant papillary lesions. Conclusion We noted a high frequency of malignancy in papillary breast lesions. Moreover, malignant papillary lesions were significantly associated with higher age and larger tumor size. Cureus 2020-10-18 /pmc/articles/PMC7671300/ /pubmed/33214954 http://dx.doi.org/10.7759/cureus.11026 Text en Copyright © 2020, Hashmi et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pathology
Hashmi, Atif A
Faraz, Mahrukh
Rafique, Sana
Adil, Hiba
Imran, Abira
Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast
title Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast
title_full Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast
title_fullStr Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast
title_full_unstemmed Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast
title_short Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast
title_sort spectrum of papillary breast lesions according to world health organization classification of papillary neoplasms of breast
topic Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671300/
https://www.ncbi.nlm.nih.gov/pubmed/33214954
http://dx.doi.org/10.7759/cureus.11026
work_keys_str_mv AT hashmiatifa spectrumofpapillarybreastlesionsaccordingtoworldhealthorganizationclassificationofpapillaryneoplasmsofbreast
AT farazmahrukh spectrumofpapillarybreastlesionsaccordingtoworldhealthorganizationclassificationofpapillaryneoplasmsofbreast
AT rafiquesana spectrumofpapillarybreastlesionsaccordingtoworldhealthorganizationclassificationofpapillaryneoplasmsofbreast
AT adilhiba spectrumofpapillarybreastlesionsaccordingtoworldhealthorganizationclassificationofpapillaryneoplasmsofbreast
AT imranabira spectrumofpapillarybreastlesionsaccordingtoworldhealthorganizationclassificationofpapillaryneoplasmsofbreast